Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Clinical trial NCT04789980 · COMPLETED

Trial details

NCT number: NCT04789980
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2021-01-29
Primary completion: 2025-06-24
Enrollment: 799

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.